| Volume | 136 |
| Open | 25.06 |
| Bid (Size) | 23.50 (200) |
| Ask (Size) | 37.54 (200) |
| Prev. Close | 24.40 |
| Today's Range | 25.06 - 25.06 |
| 52wk Range | 22.89 - 27.94 |
| Shares Outstanding | 1,300 |
| Dividend Yield | 1.65% |
Amplify Weight Loss Drug & Treatment ETF (THNR) traded between $22.89 and $27.94 over the past 52 weeks and last traded at $25.06, 10.3% below its 52-week high. Over the past week it ranged between $23.50 and $24.74.
THNR was +6.1% over the past year, +0.6% over six months, -1.4% year to date, +4.3% in the last week.
Over the past 12 months THNR returned +6.1% versus DIA (Dow) +12.3%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.3% and IWM (Russell 2000) +11.1%.
THNR most recently traded 136 shares against a 3-month average daily volume of 1.3K.